Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine

Bibliographic Details
Title: Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine
Contributors: Dragoi, Cristina Manuela, Nicolae, Alina Crenguța, Dumitrescu, Ion-Bogdan
Publisher Information: Basel: MDPI - Multidisciplinary Digital Publishing Institute, 2024.
Publication Year: 2024
Subject Terms: muscle invasive bladder cancer, exosomes, biomarkers, bladder cancer screening, bladder cancer diagnosis, spinal muscular atrophy, compound motor action potential, the children’s hospital of Philadelphia infant test of neuromuscular disorders, hammersmith functional motor scale expanded, bradykinin, neuropathic pain, chemotherapy, allodynia, CIPN, Alzheimer’s disease, antihypertensives, amyloid, tau, angiotensin-converting enzyme inhibitor, angiotensin II receptor blockers, therapeutic strategies, personalized medicine, perampanel, epilepsy, population pharmacokinetics, NONMEM, therapeutic drug monitoring, neurotensin subtype 1 receptor, radiolabeled neurotensin, targeted tumor imaging, Tc-99m, metabolic stability, neprilysin, angiotensin-converting enzyme, peptidase-inhibition, cardiovascular diseases, DNA markers, non-coding RNA, selegiline, anti-obesity, adipogenesis, lipogenesis, lipolysis, eWAT browning, anamorelin, metabolism, molecular networking, LC-MS/MS, GHSR agonist, chronic lymphocytic leukemia, genetic alterations, inhibitors of Bruton tyrosine kinase, TP53 mutation, immunoglobulin heavy chain variable region mutated, model-informed precision dosing, procalcitonin, inflammation, biomarker, antibiotics, critically ill, pharmacodynamic target attainment, precision medicine, in silico, clinical pharmacology, computational tools, patient-centered healthcare, solid oral dosage form (SODF), medicine administration, difficulty swallowing, dysphagia, medicine manipulation, inpatient, Theatre studies, Oncology, Music
More Details: In the dynamic realm of modern medicine, we stand at a pivotal juncture where the convergence of disease, drugs, and patient individuality is shaping a new paradigm. The field is transitioning from traditional drug development towards personalized therapeutic strategies tailored to the unique physiology of each person. Over past decades, significant progress in preventive measures, diagnostic techniques, and treatment approaches has greatly improved patient care. However, the successful implementation of personalized medicine hinges on a thorough understanding of pathogenesis, therapeutic agents, biochemical mechanisms, drug interactions, and patient-specific factors.In this context, the objective of this reprint, "Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine", is to provide a comprehensive collection of the latest research, showcasing the current state of knowledge and forecasting future trends in drug development and clinical practice. This reprint emphasizes the importance of understanding biochemical mechanisms of action, innovative drug formulations, and robust preclinical and clinical evaluations, including efficacy, pharmacokinetics, and toxicity, all within the framework of precision and personalized medicine.
Document Type: eBook
File Description: application/octet-stream
Language: English
ISBN: 978-3-7258-2296-6
978-3-7258-2295-9
DOI: 10.3390/books978-3-7258-2295-9
Access URL: https://directory.doabooks.org/handle/20.500.12854/152842
https://mdpi.com/books/pdfview/book/10075
Rights: Attribution 4.0 International
open access
URL: http://purl.org/coar/access_right/c_abf2
URL: https://creativecommons.org/licenses/by/4.0/
Notes: ONIX_20250220_9783725822966_206
Accession Number: edsdob.20.500.12854.152842
Database: Directory of Open Access Books
More Details
ISBN:9783725822966
9783725822959
DOI:10.3390/books978-3-7258-2295-9
Language:English